We present a case of a 70-year-old woman with a history of moderately differentiated rectal adenocarcinoma treated with neoadjuvant radiotherapy and surgery who developed metastatic disease with a KRAS G12V mutation. Here, KRAS is linked to metastatic neoplasm.